Wolverine Trading
CTXR icon

Wolverine Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Wolverine Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-780
Closed -$13.3K – 4595
2023
Q3 		$13.3K Sell
780
-148
-16% -$3.52K ﹤0.01% 4357
2023
Q2 		$27.4K Buy
928
+244
+36% +$8.03K ﹤0.01% 4067
2023
Q1 		$20K Sell
684
-676
-50% -$19.5K ﹤0.01% 4009
2022
Q4 		$27K Buy
1,360
+196
+17% +$5.35K ﹤0.01% 3693
2022
Q3 		$37K Buy
+1,164
New +$32K ﹤0.01% 4234
2022
Q2 		– Sell
-688
Closed -$30K – 4685
2022
Q1 		$30K Buy
+688
New +$27.2K ﹤0.01% 5190

Other funds holding CTXR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wolverine Trading's CTXR Position: Q2 2022 in Review

Wolverine Trading sold out of Citius Pharmaceuticals (CTXR) in Q2 2022, closing a stake of 437 shares — an estimated $19K sold.

Wolverine Trading first reported a position in CTXR in Q1 2022 and held it in 1 quarter. The position peaked at $19K in Q1 2022. 60 funds tracked by Wall St. Rank hold CTXR as of Q2 2022.

  • Wolverine Trading reported no remaining Citius Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 437 Citius Pharmaceuticals shares in Q2 2022, an estimated $19K.
  • Wolverine Trading first reported a position in Citius Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Wolverine Trading's Citius Pharmaceuticals position peaked at $19K in Q1 2022.
  • 60 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.